{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T21:21:50Z","timestamp":1790976110650,"version":"4.1.0"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>Hyponatraemia has been reported to be a potent predictor of poor outcome in patients hospitalized for heart failure (HF). The aim of the study was to determine the prevalence and prognostic significance of hyponatraemia in a large cohort of HF outpatients followed in clinics participating in the Danish Heart Failure Clinics Network.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>The study population consisted of consecutive patients referred for HF management in 18 Danish heart failure clinics. Overall, 2863 patients (83%) had a normal plasma sodium (p-sodium) level and 602 patients (17%) had hyponatraemia with a p-sodium level &amp;lt;136 mmol\/L. Outcome data were obtained from a validated, national registry. Patients were elderly with a mean age of 68 years. The mean P\u2013[Na+] was 139.6 \u00b1 2.4 mmol\/L among patients with normonatraemia and 132.4 \u00b1 3.2 mmol\/L among patients with hyponatraemia. In multivariate Cox Proportional Hazard Models adjusted for confounders (age, gender, hospitalization within the last 90 days, loop diuretics, creatinine level, systolic blood pressure, New York Heart Association class III\u2013IV, left ventricular ejection fraction &amp;lt;0.46, ischaemic heart disease and diabetes) hyponatraemic patients had increased risk of hospitalization or death [hazard ratio (HR) 1.2 (95% confidence interval (CI) 1.0\u20131.4, P = 0.011)]. Hyponatraemia was also an independent predictor of all-cause mortality [HR 1.5 (95% CI 1.2\u20131.9, P&amp;lt; 0.001)]. There was no interaction between hyponatraemia and the covariables on outcome in the multivariable models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The presence of hyponatraemia in outpatients with HF is associated with increased risk of hospitalization or death.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/eurjhf\/hfr086","type":"journal-article","created":{"date-parts":[[2011,7,9]],"date-time":"2011-07-09T20:26:49Z","timestamp":1310243209000},"page":"968-973","source":"Crossref","is-referenced-by-count":68,"title":["Prevalence and Prognostic Significance of Hyponatraemia in Outpatients with Chronic Heart Failure"],"prefix":"10.1093","volume":"13","author":[{"given":"Louise","family":"Balling","sequence":"first","affiliation":[{"name":"Department of Cardiology, Rigshospitalet, Copenhagen \u00a0","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten","family":"Schou","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hiller\u00f8d Hospital, Hiller\u00f8d \u00a0","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Videb\u00e6k","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Odense University Hospital , Odense ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Hildebrandt","sequence":"additional","affiliation":[{"name":"Departments of Cardiology and Endocrinology, Frederiksberg Hospital , Frederiksberg ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Wiggers","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Skejby Hospital , Aarhus ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Finn","family":"Gustafsson","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Rigshospitalet, Copenhagen \u00a0","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Danish Heart Failure Clinics Network","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,2,18]]},"reference":[{"key":"2026020203290954200_ejhfhfr086-bib-0001","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s10741-008-9109-7","article-title":"Hyponatremia in heart failure","volume":"14","author":"Gerasimos Filippatos","year":"2009","journal-title":"Heart Fail Rev"},{"issue":"suppl","key":"2026020203290954200_ejhfhfr086-bib-0002","doi-asserted-by":"crossref","first-page":"2B","DOI":"10.1016\/j.amjcard.2005.03.002","article-title":"Hyponatremia in congestive heart failure","volume":"95","author":"Oren","year":"2005","journal-title":"Am J Cardiol"},{"key":"2026020203290954200_ejhfhfr086-bib-0003","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.cardfail.2009.12.021","article-title":"The critical link of hypervolemia and hyponatremia in heart failure and the potential role of arginine vasopressin antagonists","volume":"16","author":"Ghali","year":"2010","journal-title":"J Card Fail"},{"key":"2026020203290954200_ejhfhfr086-bib-0004","article-title":"Significance of hyponatremia in heart failure","author":"Bettari","year":"2010","journal-title":"Heart Fail Rev"},{"key":"2026020203290954200_ejhfhfr086-bib-0005","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.ejheart.2008.08.005","article-title":"ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)","volume":"10","author":"Dickstein","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"2026020203290954200_ejhfhfr086-bib-0006","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ejheart.2004.03.016","article-title":"Treatment with beta-blockers in nurse-led heart failure clinics: titration efficacy and predictors of failure","volume":"7","author":"Gustafsson","year":"2005","journal-title":"Eur J Heart Fail"},{"key":"2026020203290954200_ejhfhfr086-bib-0007","doi-asserted-by":"crossref","first-page":"E13","DOI":"10.1002\/clc.20560","article-title":"Low Serum Sodium as a Poor Prognostic Indicator for Mortality in Congestive Heart Failure Patients","volume":"33","author":"Dewolfe","year":"2010","journal-title":"Clin Cardiol"},{"key":"2026020203290954200_ejhfhfr086-bib-0008","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.ejheart.2007.05.008","article-title":"Treatment with beta-blockers in nurse-led heart failure clinics: titration efficacy and predictors of failure","volume":"9","author":"Gustafsson","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"2026020203290954200_ejhfhfr086-bib-0009","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0895-4356(02)00591-7","article-title":"The validity of the diagnosis of acute myocardial infarction in routine statistics: a comparison of mortality and hospital discharge data with the Danish MONICA registry","volume":"56","author":"Madsen","year":"2003","journal-title":"J Clin Epidemiol"},{"key":"2026020203290954200_ejhfhfr086-bib-0010","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1056\/NEJM200005253422107","article-title":"Hyponatremia","volume":"342","author":"Adrogu\u00e9","year":"2000","journal-title":"N Engl J Med"},{"key":"2026020203290954200_ejhfhfr086-bib-0011","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1161\/01.CIR.0000165065.82609.3D","article-title":"Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: Results From the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) Study","volume":"111","author":"Klein","year":"2005","journal-title":"Circulation"},{"key":"2026020203290954200_ejhfhfr086-bib-0012","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1001\/jama.291.16.1963","article-title":"Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial","volume":"291","author":"Gheorghiade","year":"2004","journal-title":"JAMA"},{"key":"2026020203290954200_ejhfhfr086-bib-0013","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/eurheartj\/ehl542","article-title":"Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry","volume":"28","author":"Gheorghiade","year":"2007","journal-title":"Eur Heart J"},{"key":"2026020203290954200_ejhfhfr086-bib-0014","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jama.297.12.1319","article-title":"Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial","volume":"297","author":"Konstam","year":"2007","journal-title":"JAMA"},{"key":"2026020203290954200_ejhfhfr086-bib-0015","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/eurheartj\/ehp032","article-title":"The MUSIC Risk score: a simple method for predicting mortality in ambulatory patients with chronic heart failure","volume":"30","author":"Vazquez","year":"2009","journal-title":"Eur Heart J"},{"key":"2026020203290954200_ejhfhfr086-bib-0016","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1136\/hrt.2003.021733","article-title":"Predicting sudden death in patients with mild to moderate chronic heart failure","volume":"90","author":"Kearney","year":"2004","journal-title":"Heart"},{"key":"2026020203290954200_ejhfhfr086-bib-0017","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1093\/eurjhf\/hfq079","article-title":"Predictors of long-term (4-year) mortality in elderly and young patients with acute heart failure","volume":"12","author":"Barsheshet","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"2026020203290954200_ejhfhfr086-bib-0018","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1527-5299.2005.04180.x","article-title":"Hyponatremia and heart failure\u2014pathophysiology and implications","volume":"11","author":"Sica","year":"2005","journal-title":"Congest Heart Fail"},{"key":"2026020203290954200_ejhfhfr086-bib-0019","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1210\/jcem-59-5-924","article-title":"Hyponatremia in congestive heart failure: implications for neurohumoral activation and responses to orthostasis","volume":"59","author":"Lilly","year":"1984","journal-title":"J Clin Endocrinol Metab"},{"key":"2026020203290954200_ejhfhfr086-bib-0020","first-page":"IV80","article-title":"Role of neurohormonal mechanisms in determining survival in patients with severe chronic heart failure","volume":"75","author":"Packer","year":"1987","journal-title":"Circulation"},{"key":"2026020203290954200_ejhfhfr086-bib-0021","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1056\/NEJM198107303050506","article-title":"Radioimmunoassay of plasma arginine vasopressin in hyponatremic patients with congestive heart failure","volume":"305","author":"Szatalowicz","year":"1981","journal-title":"N Engl J Med"},{"key":"2026020203290954200_ejhfhfr086-bib-0022","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0735-1097(83)80040-0","article-title":"Increased plasma arginine vasopressin levels in patients with congestive heart failure","volume":"1","author":"Goldsmith","year":"1983","journal-title":"J Am Coll Cardiol"},{"key":"2026020203290954200_ejhfhfr086-bib-0023","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1161\/CIRCULATIONAHA.109.933275","article-title":"Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival","volume":"122","author":"Testani","year":"2010","journal-title":"Circulation"},{"key":"2026020203290954200_ejhfhfr086-bib-0024","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0735-1097(84)80364-2","article-title":"Relation between serum sodium concentration and the hemodynamic and clinical responses to converting enzyme inhibition with captopril in severe heart failure","volume":"3","author":"Packer","year":"1984","journal-title":"J Am Coll Cardiol"},{"key":"2026020203290954200_ejhfhfr086-bib-0025","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0735-1097(87)80278-4","article-title":"Identification of hyponatremia as a risk factor for the development of functional renal insufficiency during converting enzyme inhibition in severe chronic heart failure","volume":"10","author":"Packer","year":"1987","journal-title":"J Am Coll Cardiol"},{"key":"2026020203290954200_ejhfhfr086-bib-0026","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1161\/01.CIR.96.7.2197","article-title":"Prognostic value of bisoprolol-induced hemodynamic effects in heart failure during the Cardiac Insufficiency BIsoprolol Study (CIBIS)","volume":"96","author":"Lechat","year":"1997","journal-title":"Circulation"},{"key":"2026020203290954200_ejhfhfr086-bib-0027","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/0735-1097(94)90773-0","article-title":"Beta-blockers in heart failure: promising or proved?","volume":"23","author":"Doughty","year":"1994","journal-title":"J Am Coll Cardiol"},{"key":"2026020203290954200_ejhfhfr086-bib-0028","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.amjmed.2007.09.001","article-title":"Hyponatremia treatment guidelines 2007: expert panel recommendations","volume":"120","author":"Verbalis","year":"2007","journal-title":"Am J Med"},{"key":"2026020203290954200_ejhfhfr086-bib-0029","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/eurjhf\/hfq226","article-title":"Short- and long-term treatment of dilutional hyponatraemia with satavaptan, a selective arginine vasopressin V2-receptor antagonist: the DILIPO study","volume":"13","author":"Aronson","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"2026020203290954200_ejhfhfr086-bib-0030","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/eurjhf\/hfq236","article-title":"Hyponatraemia and vasopressin in heart failure: markers or mediators?","volume":"13","author":"Konstam","year":"2011","journal-title":"Eur J Heart Fail"}],"container-title":["European Journal of Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1093%2Feurjhf%2Fhfr086","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/13\/9\/968\/66469278\/eurjhf_13_9_968.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/13\/9\/968\/66469278\/eurjhf_13_9_968.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T08:29:18Z","timestamp":1770020958000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjhf\/article\/13\/9\/968\/8430868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,1]]},"references-count":30,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2014,2,18]]},"published-print":{"date-parts":[[2011,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/eurjhf\/hfr086","relation":{},"ISSN":["1388-9842","1879-0844"],"issn-type":[{"value":"1388-9842","type":"print"},{"value":"1879-0844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2011,9]]},"published":{"date-parts":[[2011,9,1]]}}}